Eye Health America

eyehealthamerica.com

Eye Health America partners with eye care practices and ambulatory surgery centers to provide superior clinical care. Our member practices offer full-service eye care from routine eye exams, contact lenses and glasses to medical ophthalmology and surgery including cataract, cornea, retina, glaucoma, pediatrics and oculoplastics. We support practice groups and ASCs as they grow locations and service offerings, enabling them to focus on delivering the highest quality outcomes and meeting a rapidly growing need for eye care. Visit www.eyehealthamerica.com to learn more.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

CELL AND GENE THERAPY, MEDICAL

SANISURE ANNOUNCES THE ACQUISITION OF A LEADING SILICONE EXTRUSION FACILITY IN TWINSBURG, OHIO

Sanisure | December 21, 2022

news image

Sanisure, a leading, vertically-integrated player in the single- use bioprocessing technology space, is pleased to announce the acquisition of Medical Elastomer Development, Inc a silicone extrusion facility from Q Holding, a 3i portfolio company. This state-of-the-art facility located in Twinsburg, Ohio, serves many industry- leading customers in both the medical device and bioprocessing markets. The acquisition further advances our commitment to become a leading provider of crit...

Read More

INDUSTRIAL IMPACT

IMAGINAB EXECUTES NEW LICENSE AND SUPPLY AGREEMENT FOR CD8 IMMUNOPET TECHNOLOGY WITH TRISALUS LIFE SCIENCES

ImaginAb | November 23, 2022

news image

ImaginAb Inc., a global biotechnology company developing 89Zr crefmirlimab berdoxam imaging agent and radiopharmaceutical therapy products, is pleased to announce the signing of a new non-exclusive License and Supply Agreement with TriSalus Life Sciences, Inc. an oncology therapeutics company integrating immunotherapy with disruptive delivery technology to transform the treatment paradigm for patients with liver and pancreatic tumors. Under the terms of the agreement, ImaginAb wil...

Read More

INDUSTRIAL IMPACT

NOVO HOLDINGS LEADS US$21M SERIES A FINANCING IN BIOMILQ

Novo Holdings | October 21, 2021

news image

BIOMILQ is developing a novel infant feeding option, derived from human mammary cells, to better meet infants' nutritional needs and with a lower carbon footprint than traditional bovine-based infant formula. Earlier this year, BIOMILQ announced it had successfully produced a milk product with many of the same macronutrients that are known to be abundantly present in breastmilk in its lab based in Research Triangle Park in North Carolina, US. In the US, it is estim...

Read More

INDUSTRIAL IMPACT

ILLUMINA LAUNCHES STRATEGIC RESEARCH COLLABORATION WITH ASTRAZENECA TO ACCELERATE DRUG TARGET DISCOVERY

Illumina, Inc. | October 12, 2022

news image

Illumina Inc. a global leader in DNA sequencing and array-based technologies, announced a strategic research collaboration with AstraZeneca, a global, science-led biopharmaceutical company, to accelerate drug target discovery by combining their strengths in artificial intelligence (AI) based genome interpretation and genomic analysis techniques along with industry expertise. The collaboration will evaluate whether a combined framework of these technologies can increase the yield and confidence o...

Read More
news image

CELL AND GENE THERAPY, MEDICAL

SANISURE ANNOUNCES THE ACQUISITION OF A LEADING SILICONE EXTRUSION FACILITY IN TWINSBURG, OHIO

Sanisure | December 21, 2022

Sanisure, a leading, vertically-integrated player in the single- use bioprocessing technology space, is pleased to announce the acquisition of Medical Elastomer Development, Inc a silicone extrusion facility from Q Holding, a 3i portfolio company. This state-of-the-art facility located in Twinsburg, Ohio, serves many industry- leading customers in both the medical device and bioprocessing markets. The acquisition further advances our commitment to become a leading provider of crit...

Read More
news image

INDUSTRIAL IMPACT

IMAGINAB EXECUTES NEW LICENSE AND SUPPLY AGREEMENT FOR CD8 IMMUNOPET TECHNOLOGY WITH TRISALUS LIFE SCIENCES

ImaginAb | November 23, 2022

ImaginAb Inc., a global biotechnology company developing 89Zr crefmirlimab berdoxam imaging agent and radiopharmaceutical therapy products, is pleased to announce the signing of a new non-exclusive License and Supply Agreement with TriSalus Life Sciences, Inc. an oncology therapeutics company integrating immunotherapy with disruptive delivery technology to transform the treatment paradigm for patients with liver and pancreatic tumors. Under the terms of the agreement, ImaginAb wil...

Read More
news image

INDUSTRIAL IMPACT

NOVO HOLDINGS LEADS US$21M SERIES A FINANCING IN BIOMILQ

Novo Holdings | October 21, 2021

BIOMILQ is developing a novel infant feeding option, derived from human mammary cells, to better meet infants' nutritional needs and with a lower carbon footprint than traditional bovine-based infant formula. Earlier this year, BIOMILQ announced it had successfully produced a milk product with many of the same macronutrients that are known to be abundantly present in breastmilk in its lab based in Research Triangle Park in North Carolina, US. In the US, it is estim...

Read More
news image

INDUSTRIAL IMPACT

ILLUMINA LAUNCHES STRATEGIC RESEARCH COLLABORATION WITH ASTRAZENECA TO ACCELERATE DRUG TARGET DISCOVERY

Illumina, Inc. | October 12, 2022

Illumina Inc. a global leader in DNA sequencing and array-based technologies, announced a strategic research collaboration with AstraZeneca, a global, science-led biopharmaceutical company, to accelerate drug target discovery by combining their strengths in artificial intelligence (AI) based genome interpretation and genomic analysis techniques along with industry expertise. The collaboration will evaluate whether a combined framework of these technologies can increase the yield and confidence o...

Read More